Coherus BioSciences
CHRS
#8510
Rank
A$0.30 B
Marketcap
A$2.52
Share price
9.86%
Change (1 day)
3.49%
Change (1 year)

Market capitalization of Coherus BioSciences (CHRS)

Market cap: A$0.30 Billion

As of January 2026 Coherus BioSciences has a market cap of A$0.30 Billion. This makes Coherus BioSciences the world's 8510th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Coherus BioSciences from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.30 B26.7%
2025A$0.24 B-13.04%
2024A$0.27 B-49.3%
2023A$0.54 B-39.87%
2022A$0.90 B-46.45%
2021A$1.69 B3.8%
2020A$1.62 B-10.01%
2019A$1.80 B106.23%
2018A$0.87 B32.56%
2017A$0.66 B-61.17%
2016A$1.70 B38.67%
2015A$1.22 B85.36%
2014A$0.66 B

End of Day market cap according to different sources

On Jan 8th, 2026 the market cap of Coherus BioSciences was reported to be:

A$0.27 Billion
by Nasdaq info icon info icon
A$0.27 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Acorda Therapeutics
ACOR
A$1.22 M-99.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
A$9.22 B 2,934.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$263.60 B 86,586.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$14.08 B 4,531.88%๐Ÿ‡บ๐Ÿ‡ธ USA